MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
暂无分享,去创建一个
M. Sormani | E. Radue | M. Freedman | L. Brundin | M. Battaglia | A. Uccelli | J. Wuerfel | P. Soelberg Sørensen | A. Laroni | M. Clanet | P. Muraro | S. Nabavi | R. Oliveri | J. Sellner | Ó. Fernández